699O Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC): Association between clinical outcomes and exploratory biomarkers
| Autor: | Powles, T.B., Loriot, Y., Bellmunt, J., Sternberg, C.N., Sridhar, S., Petrylak, D.P., Tambaro, R., Dourthe, L.M., Alvarez-Fernandez, C., Aarts, M., Mu, X.J., Ching, K.A., Pu, J., Roychoudhury, S., Davis, C.B., di Pietro, A., Grivas, P. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S552-S553 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|